Literature DB >> 8285145

Independent effects of interleukin 1 on proteoglycan synthesis and proteoglycan breakdown of bovine articular cartilage in vitro.

J Neidel1, U Zeidler.   

Abstract

We studied the effects of human recombinant interleukin-1 beta on proteoglycan metabolism of bovine articular cartilage in organ culture. IL-1 was more potent in inhibiting synthesis (IC50 4 ng/mL) than in stimulating breakdown of proteoglycans (EC50 200 ng/mL). Inhibition of proteoglycan synthesis began to plateau earlier (2 days) than stimulation of proteoglycan release (4 days). Both effects could be neutralized with a polyclonal anti-IL-1 beta antibody; however, higher antibody titers were required to block IL-1 effects on proteoglycan synthesis than to neutralize those on proteoglycan release. Chloroquine, but not hydrocortisone, blocked IL-1-mediated proteoglycan breakdown. Both drugs, however, augmented IL-1-induced inhibition of proteoglycan synthesis. Our data suggest that the effects of IL-1 on articular cartilage proteoglycan synthesis and proteoglycan breakdown can be regulated independently.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8285145     DOI: 10.1007/BF01975718

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  50 in total

1.  Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation.

Authors:  J Saklatvala; F Guesdon
Journal:  J Rheumatol Suppl       Date:  1992-01

2.  IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.

Authors:  T A Bird; J Saklatvala
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

3.  Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation.

Authors:  F Ollivierre; U Gubler; C A Towle; C Laurencin; B V Treadwell
Journal:  Biochem Biophys Res Commun       Date:  1986-12-30       Impact factor: 3.575

4.  Concentration of interleukin-1 beta in serum and synovial fluid in patients with rheumatoid arthritis and those with osteoarthritis.

Authors:  K Mannami; T Mitsuhashi; H Takeshita; K Okada; A Kuzuhara; F Yamashita; K Sakakida
Journal:  Nihon Seikeigeka Gakkai Zasshi       Date:  1989-11

5.  The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants.

Authors:  J J Nietfeld; B Wilbrink; W Den Otter; J Huber; O Huber-Bruning
Journal:  J Rheumatol       Date:  1990-06       Impact factor: 4.666

6.  Synovial fluid concentration of five different cytokines in rheumatic diseases.

Authors:  C I Westacott; J T Whicher; I C Barnes; D Thompson; A J Swan; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

7.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

8.  Effects of antirheumatoid drugs on the production and action of porcine catabolin.

Authors:  H Sheppeard; L M Pilsworth; B Hazleman; J T Dingle
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

9.  Transcriptional regulation of the human prointerleukin 1 beta gene.

Authors:  M J Fenton; B D Clark; K L Collins; A C Webb; A Rich; P E Auron
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

10.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

Authors:  E R Pettipher; G A Higgs; B Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  9 in total

1.  Beneficial effects of cerium oxide nanoparticles in development of chondrocyte-seeded hydrogel constructs and cellular response to interleukin insults.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Irina V Chernyshova; Katherine Wood; Clark Tung-Hui Hung; Ponisseril Somasundaran
Journal:  Tissue Eng Part A       Date:  2014-06-25       Impact factor: 3.845

2.  Plasminogen modulation of IL-1-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors: PAI-1, alpha 2-antiplasmin, alpha 1-PI, alpha 2-macroglobulin and TIMP.

Authors:  J Oleksyszyn; A J Augustine
Journal:  Inflamm Res       Date:  1996-09       Impact factor: 4.575

3.  Effects of hexosamines and omega-3/omega-6 fatty acids on pH regulation by interleukin 1-treated isolated bovine articular chondrocytes.

Authors:  Amanda L Tattersall; Robert J Wilkins
Journal:  Pflugers Arch       Date:  2008-01-17       Impact factor: 3.657

4.  Effects of methotrexate on normal articular cartilage in vitro and in vivo.

Authors:  J Neidel; L Sova; B Schroers; F Sintermann; O Manzke; H Bohlen
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

5.  Composition-function relationships during IL-1-induced cartilage degradation and recovery.

Authors:  A W Palmer; C G Wilson; E J Baum; M E Levenston
Journal:  Osteoarthritis Cartilage       Date:  2009-03-03       Impact factor: 6.576

6.  Insulin-like growth factor I accelerates recovery of articular cartilage proteoglycan synthesis in culture after inhibition by interleukin 1.

Authors:  J Neidel; M Schulze; L Sova
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

7.  Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis.

Authors:  J Neidel; M Schulze; J Lindschau
Journal:  Inflamm Res       Date:  1995-05       Impact factor: 4.575

Review 8.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

9.  RNA Interference Mediated Interleukin-1β Silencing in Inflamed Chondrocytes Decreases Target and Downstream Catabolic Responses.

Authors:  Kyla F Ortved; Bethany S Austin; Michael S Scimeca; Alan J Nixon
Journal:  Arthritis       Date:  2016-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.